Low brain oxygen in chronic disease (VIDEO)

Dr. Jarred Younger is a neuroscientist and neuroimaging researcher based at the University of Alabama at Birmingham, where his lab investigates the brain mechanisms underlying chronic pain and fatigue conditions. In a 2025 video lecture, he discusses research using brain oxygen-level-dependent (BOLD) MRI to detect reduced oxygen availability in the brains of people with autonomic conditions — providing imaging-level evidence for the cerebral perfusion impairment that the orthostatic physiology literature has been documenting from outside the brain using transcranial Doppler and other methods. The finding matters because it connects what the autonomic literature has established about reduced cerebral blood flow to what the brain imaging literature can see about the consequences of that reduction at the tissue level.

What Brain Oxygen Imaging Measures

Blood oxygen level-dependent MRI — the same BOLD signal used in functional MRI studies — is sensitive to the ratio of oxygenated to deoxygenated hemoglobin in brain tissue. When a brain region receives adequate blood flow with adequate oxygen content, the BOLD signal reflects normal oxygenation. When blood flow to that region is reduced, or when the oxygen extraction from arriving blood exceeds normal levels because the supply is insufficient, the BOLD signal reflects relative deoxygenation — a measurable sign that the tissue is not receiving the oxygen its metabolic activity demands.

Younger's lab uses resting-state BOLD MRI to map brain oxygenation across conditions without requiring a task or cognitive challenge. This resting approach is particularly relevant for ME/CFS and dysautonomia, where cognitive and physical demands exacerbate symptoms and where what happens at baseline — when the patient is lying still and supposedly at rest — is already abnormal. A resting BOLD signal that shows reduced oxygenation in specific brain regions tells you that even the baseline, low-demand state involves a perfusion shortfall. The brain is not getting enough oxygen to sustain normal resting function.

What Younger's Research Found

Younger's research identified regions of reduced brain oxygenation in patients with chronic fatigue and autonomic conditions compared to healthy controls. The specific pattern of regional hypoxia varies across patients, reflecting the heterogeneity of perfusion impairment across the spectrum of conditions his research covers. But the consistent finding is that the brain imaging reveals a biological signal — reduced tissue oxygenation — that standard clinical workup does not capture and that is invisible on conventional MRI scans that are read as normal.

This is the imaging-level confirmation of what the transcranial Doppler research has been documenting from the vascular side. Transcranial Doppler shows reduced blood flow velocity in the cerebral arteries during orthostatic challenge. Younger's BOLD approach shows the tissue-level consequence of that reduced flow: regions of the brain that are receiving less oxygen than they need. The two approaches are measuring the same phenomenon at different points in the causal chain — reduced flow leading to reduced tissue oxygenation leading to impaired neurological function.

The cognitive impairment, fatigue, and brain fog that patients with ME/CFS and dysautonomia report are not mysteries when contextualized with these imaging findings. Brain regions that are hypoxic function poorly. Neurons that are not receiving adequate oxygen generate reduced action potentials, fail to maintain synaptic transmission at normal fidelity, and struggle to sustain the coordinated network activity that cognitive function requires. The cognitive symptoms are the expected neurological output of tissue hypoxia — not a metaphor, not a psychological overlay, but the functional consequence of measurably insufficient oxygen delivery to brain tissue.

Why This Level of Evidence Matters

Brain imaging that shows reduced tissue oxygenation occupies a different evidential position than patient self-report or even performance-based cognitive testing. It is a direct measure of a physical quantity — oxygen concentration in brain tissue — using a validated imaging technology. It is the kind of evidence that moves conditions from "no objective findings" to "objectively documented physiological abnormality" in clinical and research settings.

The challenge for patients with ME/CFS and dysautonomia is that standard clinical MRI is typically read as normal. A radiologist reading a standard T1 or T2 MRI is looking for structural abnormalities — tumors, lesions, atrophy, white matter changes. They are not looking at perfusion or oxygenation, and standard sequences do not provide that information. A patient can have measurably impaired brain oxygenation that produces cognitive and neurological symptoms, receive a standard MRI, and be told their brain scan is normal — because the scan was not measuring what is wrong.

Younger's work represents a line of imaging research that is moving toward the right measurements. The BOLD-based oxygenation approach is not standard clinical practice. It is research methodology. But it is methodology that has produced findings consistent with the rest of the ME/CFS and dysautonomia literature — findings that together build toward the conclusion that reduced cerebral perfusion and its tissue consequences are central to the experience of these conditions, not incidental findings or artifacts of measurement.

Connecting Imaging to the Perfusion Literature

Younger's brain oxygenation findings connect directly to the body of work on cerebral blood flow in ME/CFS and orthostatic intolerance. The Christopoulos 2025 systematic review of 118 studies established that cerebral blood flow is significantly reduced in both conditions, with additive impairment when both are present. The van Campen and Rowe research documented that bedbound ME/CFS patients show CBF reduction at as little as 20 degrees of tilt. These studies measured blood flow velocity in cerebral arteries. Younger's imaging measures what happens to brain tissue when that flow velocity is chronically reduced: the tissue becomes hypoxic.

The full chain — impaired autonomic regulation → inadequate cardiovascular compensation for orthostatic and exertional stress → reduced cerebral blood flow velocity → reduced brain tissue oxygenation → impaired neurological function → cognitive and fatigue symptoms — is documented at each step by independent lines of research. Younger's work occupies the third-to-last link in that chain. It is not a standalone finding. It is the imaging-level confirmation that reduced blood flow produces the tissue oxygenation shortfall that the rest of the literature predicts it should. The picture these studies collectively describe is of a condition whose primary mechanism is impaired delivery of oxygen to the brain — not a condition of psychological origin, not a condition of mysterious unknown etiology, but a delivery problem with measurable consequences at every level from vascular flow to tissue oxygenation to cognitive function.